Peripheral artery disease and outcomes: how can we improve risk prediction?
Eur Heart J
.
2024 May 21;45(19):1750-1752.
doi: 10.1093/eurheartj/ehae154.
Authors
Mounica Yanamandala
1
,
Guillaume Goudot
2
,
Marie Denise Gerhard-Herman
1
Affiliations
1
Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02116, USA.
2
Université Paris Cité, Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.
PMID:
38607986
PMCID:
PMC11107121
(available on
2025-04-12
)
DOI:
10.1093/eurheartj/ehae154
No abstract available
MeSH terms
Humans
Peripheral Arterial Disease* / diagnosis
Peripheral Arterial Disease* / epidemiology
Prognosis
Risk Assessment / methods
Risk Factors
Grants and funding
NH/NIH HHS/United States
NH/NIH HHS/United States
TR/NCATS NIH HHS/United States
Progeria Research Foundation